The Genetics of Wolf-Hirschhorn Syndrome: Deletions and Testing
At a Glance
Wolf-Hirschhorn syndrome results from a missing piece of chromosome 4 at 4p16.3. Microarray testing measures the deletion’s size and location, while parental chromosome testing helps show whether it happened by chance or came from a balanced chromosome swap.
Genetic testing can feel like a foreign language. When you are told your child has a deletion on chromosome 4, you are essentially being told that a small “instruction manual” for development is missing. Understanding the specifics of this deletion—how big it is (measured in units called megabases or Mb), which genes are gone, and how it happened—can help you and your medical team plan for the future.
The Missing Piece: 4p16.3
Each of us typically has 46 chromosomes, arranged in 23 pairs. One pair is “Chromosome 4.” Chromosomes have a short arm (called p) and a long arm (called q). Wolf-Hirschhorn syndrome (WHS) happens when a piece of the short arm is missing, specifically at a location called 4p16.3 [1][2].
Because this area contains several important genes, losing them affects how the body and brain develop. This is known as a contiguous gene syndrome, meaning the symptoms are associated with the combined loss of several neighboring genes rather than just one [2].
Key Genes and Their Associations
While many genes may be missing in a deletion, researchers have identified a few “heavy hitters” that contribute to the core features of WHS. It is important to remember that these are associations found across large groups, not perfect predictions for an individual:
- NSD2 (formerly WHSC1): This gene is a master regulator. Its loss is strongly associated with the characteristic facial features, slow growth, and developmental delays seen in WHS [3][4].
- LETM1: This gene helps manage the “batteries” of our cells (mitochondria). Its loss has been proposed as a major contributor to the seizure susceptibility seen in WHS, though losing it does not guarantee seizures will occur [5][6].
- MSX1: This gene is involved in the development of the face and teeth. Its absence is a plausible contributor to dental issues or specific facial structures [7][2].
How We Find the Deletion: Testing Methods
Not all genetic tests are the same. You may hear your doctors talk about two main types:
- Chromosomal Microarray (CMA): This is a preferred, high-powered test that looks across the entire genome for missing or extra pieces of DNA [8]. It provides the exact coordinates and size of the deletion [9]. However, CMA cannot detect if chromosomes have simply swapped places without gaining or losing material.
- Karyotype: This is a test where scientists look at chromosomes under a microscope. While it can see large missing pieces or major structural changes, it often misses smaller WHS deletions [10][11].
Does Deletion Size Matter?
In general, cohort studies show a correlation between the size of the deletion and the severity of the symptoms, but it is not a perfect rule.
- Larger Deletions (>9 Mb): Studies show that deletions larger than 9 Mb are often associated with more significant developmental delays and more frequent or severe epilepsy [12][13].
- Small or “Interstitial” Deletions: Some children have an “interstitial” deletion, meaning a piece is missing from the middle of the arm rather than the tip (terminal deletion). These children may sometimes have milder symptoms, especially if certain “seizure-prone” regions are spared, but seizures and delays can still occur [14][12].
Every child is unique. A clinical geneticist cannot perfectly predict a child’s individual potential or outcome from deletion size alone [14].
Why Parental Testing Should Be Offered
After a child is diagnosed, doctors strongly recommend chromosome testing (a karyotype) for both parents [15]. This is not to assign blame, but to understand how the deletion happened, which is vital for understanding recurrence risks.
- De Novo (Estimated ~90% of cases): Most WHS deletions are “de novo,” meaning they happened by chance in the sperm or egg that formed the child. The parents’ chromosomes are typical, and the risk of having another child with WHS is low (though not exactly zero, due to the rare possibility of germline mosaicism) [16].
- Balanced Translocation (Estimated ~10% of cases): In some cases, a parent carries a balanced translocation. This means they have all their genetic material, but two pieces of different chromosomes have swapped places. The parent is healthy, but they have a higher risk of passing on an “unbalanced” set (like a 4p deletion) to a child [17][15].
If a balanced translocation is found, a genetic counselor can help calculate specific recurrence risks and discuss reproductive options.
Common questions in this guide
What genetic change causes Wolf-Hirschhorn syndrome?
What can a chromosomal microarray show in Wolf-Hirschhorn syndrome?
Can the size of a Wolf-Hirschhorn deletion predict how severe the condition will be?
What is the difference between a terminal and an interstitial 4p deletion?
Why should both parents have chromosome testing after a child is diagnosed with WHS?
What is the chance that another child will have Wolf-Hirschhorn syndrome?
What do the NSD2, LETM1, and MSX1 genes have to do with WHS?
Get notified when new evidence is published on Wolf-Hirschhorn syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
From Wolf-Hirschhorn syndrome to NSD2 haploinsufficiency: a shifting paradigm through the description of a new case and a review of the literature.
Wiel LC, Bruno I, Barbi E, Sirchia F
Italian journal of pediatrics 2022; (48(1)):72 doi:10.1186/s13052-022-01267-w.
PMID: 35550183 - 2
Disorders of sex development in Wolf-Hirschhorn syndrome: a genotype-phenotype correlation and MSX1 as candidate gene.
Rjiba K, Ayech H, Kraiem O, et al.
Molecular cytogenetics 2021; (14(1)):12 doi:10.1186/s13039-021-00531-8.
PMID: 33627176 - 3
De novo truncating variants in WHSC1 recapitulate the Wolf-Hirschhorn (4p16.3 microdeletion) syndrome phenotype.
Derar N, Al-Hassnan ZN, Al-Owain M, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(1)):185-188 doi:10.1038/s41436-018-0014-8.
PMID: 29892088 - 4
Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype.
Zanoni P, Steindl K, Sengupta D, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(8)):1474-1483 doi:10.1038/s41436-021-01158-1.
PMID: 33941880 - 5
Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement.
Kaiyrzhanov R, Mohammed SEM, Maroofian R, et al.
American journal of human genetics 2022; (109(9)):1692-1712 doi:10.1016/j.ajhg.2022.07.007.
PMID: 36055214 - 6
Clinical and genetic characterization of ten Egyptian patients with Wolf-Hirschhorn syndrome and review of literature.
Mekkawy MK, Kamel AK, Thomas MM, et al.
Molecular genetics & genomic medicine 2021; (9(2)):e1546 doi:10.1002/mgg3.1546.
PMID: 33217222 - 7
MSX1 gene in the etiology orofacial deformities.
Paradowska-Stolarz A
Postepy higieny i medycyny doswiadczalnej (Online) 2015; (69()):1499-504.
PMID: 27259221 - 8
Prenatal diagnosis of Wolf-Hirschhorn syndrome: Ultrasonography and molecular karyotyping results.
Zhen L, Fan SS, Huang LY, et al.
European journal of obstetrics, gynecology, and reproductive biology 2018; (225()):19-21 doi:10.1016/j.ejogrb.2018.03.047.
PMID: 29626710 - 9
[Study on clinical features and diagnostic methods of prenatal Wolf-Hirschhorn syndrome].
Wang Y, Chen X, Xue H, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2021; (38(8)):735-739 doi:10.3760/cma.j.cn511374-20200319-00183.
PMID: 34365613 - 10
Analyses of Genotypes and Phenotypes of Ten Chinese Patients with Wolf-Hirschhorn Syndrome by Multiplex Ligation-dependent Probe Amplification and Array Comparative Genomic Hybridization.
Yang WX, Pan H, Li L, et al.
Chinese medical journal 2016; (129(6)):672-8 doi:10.4103/0366-6999.177996.
PMID: 26960370 - 11
Partial Monosomy 4p and Trisomy 12q due to a t(4;12)(p16.3;q24.31) Familial Translocation in Two Cousins.
Mozer Joaquim T, Paiva Grangeiro CH, Gaona de Oliveira Gennaro F, et al.
Molecular syndromology 2020; (10(5)):264-271 doi:10.1159/000501923.
PMID: 32021597 - 12
Epilepsy in Wolf-Hirschhorn Syndrome: Clinical Insights from a Pediatric Cohort and a Review of the Literature.
Blanco-Lago R, Málaga I, Tenorio-Castaño JA, et al.
Journal of clinical medicine 2025; (14(22)) doi:10.3390/jcm14228044.
PMID: 41303083 - 13
Clinician-Based Functional Scoring and Genomic Insights for Prognostic Stratification in Wolf-Hirschhorn Syndrome.
Nevado J, Blanco-Lago R, Bel-Fenellós C, et al.
Genes 2025; (16(7)) doi:10.3390/genes16070820.
PMID: 40725476 - 14
Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome.
Ho KS, South ST, Lortz A, et al.
Journal of medical genetics 2016; (53(4)):256-63 doi:10.1136/jmedgenet-2015-103626.
PMID: 26747863 - 15
Wolf-Hirschhorn syndrome: A case series from India.
Chaudhry C, Kaur A, Panigrahi I, Kaur A
American journal of medical genetics. Part A 2020; (182(12)):3048-3051 doi:10.1002/ajmg.a.61856.
PMID: 32914558 - 16
Wolf-Hirschhorn syndrome: Prenatal diagnosis and molecular cytogenetic characterization of a de novo distal deletion of 4p (4p16.1 → pter) in a fetus with facial cleft and preaxial polydactyly.
Chen CP, Wang LK, Chern SR, et al.
Taiwanese journal of obstetrics & gynecology 2020; (59(3)):425-431 doi:10.1016/j.tjog.2020.03.016.
PMID: 32416892 - 17
Wolf-Hirschhorn Syndrome with Epibulbar Dermoid: An Unusual Association in a Patient with 4p Deletion and Functional Xp Disomy.
Bragagnolo S, Colovati ME, Guilherme RS, et al.
Cytogenetic and genome research 2016; (150(1)):17-22 doi:10.1159/000452237.
PMID: 27842301
This page about Wolf-Hirschhorn syndrome genetics and testing is for informational purposes only and does not constitute medical advice. A clinical geneticist or genetic counselor should interpret your child’s results and recurrence risk.